Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies

Heterogeneity of the main ribosomal composition represents an emerging, yet debatable, mechanism of gene expression regulation with a purported role in ribosomopathies, a group of disorders caused by mutations in ribosomal protein genes (RPs). Ribosomopathies, mysteriously relate with tissue-specifi...

Full description

Bibliographic Details
Main Authors: Christos I. Papagiannopoulos, Konstantinos A. Kyritsis, Konstantina Psatha, Dimitra Mavridou, Fani Chatzopoulou, Georgia Orfanoudaki, Michalis Aivaliotis, Ioannis S. Vizirianakis
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.805541/full
_version_ 1798030128247209984
author Christos I. Papagiannopoulos
Konstantinos A. Kyritsis
Konstantina Psatha
Konstantina Psatha
Konstantina Psatha
Konstantina Psatha
Dimitra Mavridou
Dimitra Mavridou
Fani Chatzopoulou
Fani Chatzopoulou
Georgia Orfanoudaki
Michalis Aivaliotis
Michalis Aivaliotis
Michalis Aivaliotis
Michalis Aivaliotis
Ioannis S. Vizirianakis
Ioannis S. Vizirianakis
Ioannis S. Vizirianakis
author_facet Christos I. Papagiannopoulos
Konstantinos A. Kyritsis
Konstantina Psatha
Konstantina Psatha
Konstantina Psatha
Konstantina Psatha
Dimitra Mavridou
Dimitra Mavridou
Fani Chatzopoulou
Fani Chatzopoulou
Georgia Orfanoudaki
Michalis Aivaliotis
Michalis Aivaliotis
Michalis Aivaliotis
Michalis Aivaliotis
Ioannis S. Vizirianakis
Ioannis S. Vizirianakis
Ioannis S. Vizirianakis
author_sort Christos I. Papagiannopoulos
collection DOAJ
description Heterogeneity of the main ribosomal composition represents an emerging, yet debatable, mechanism of gene expression regulation with a purported role in ribosomopathies, a group of disorders caused by mutations in ribosomal protein genes (RPs). Ribosomopathies, mysteriously relate with tissue-specific symptoms (mainly anemia and cancer predisposition), despite the ubiquitous expression and necessity of the associated RPs. An outstanding question that may shed light into disease pathogenicity and provide potential pharmacological interventions, is whether and how the ribosomal composition is modified during, the highly affected by RP mutations, process of erythroid differentiation. To address this issue, we analyzed ribosome stoichiometry using an established model of erythroid differentiation, through sucrose gradient ultracentrifugation and quantitative proteomics. We found that differentiation associates with an extensive reprogramming of the overall ribosomal levels, characterized by an increase in monosomes and a decrease in polysomes. However, by calculating a stoichiometry score for each independent ribosomal protein, we found that the main ribosomal architecture remained invariable between immature and differentiated cells. In total, none of the 78 Ribosomal Proteins (RPs- 74 core RPs, Rack1, Fau and 2 paralogs) detected was statistically different between the samples. This data was further verified through antibody-mediated quantification of 6 representative RPs. Moreover, bioinformatic analysis of whole cell proteomic data derived out of 4 additional models of erythropoiesis revealed that RPs were co-regulated across these cell types, too. In conclusion, ribosomes maintain an invariant protein stoichiometry during differentiation, thus excluding ribosome heterogeneity from a potential mechanism of toxicity in ribosomopathies and other erythroid disorders.
first_indexed 2024-04-11T19:35:13Z
format Article
id doaj.art-7dbd8079f61d48b3bf1a917842d2d83e
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-11T19:35:13Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-7dbd8079f61d48b3bf1a917842d2d83e2022-12-22T04:06:52ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-02-01910.3389/fmolb.2022.805541805541Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding RibosomopathiesChristos I. Papagiannopoulos0Konstantinos A. Kyritsis1Konstantina Psatha2Konstantina Psatha3Konstantina Psatha4Konstantina Psatha5Dimitra Mavridou6Dimitra Mavridou7Fani Chatzopoulou8Fani Chatzopoulou9Georgia Orfanoudaki10Michalis Aivaliotis11Michalis Aivaliotis12Michalis Aivaliotis13Michalis Aivaliotis14Ioannis S. Vizirianakis15Ioannis S. Vizirianakis16Ioannis S. Vizirianakis17Laboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, GreeceLaboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, GreeceFunctional Proteomics and Systems Biology (FunPATh)—Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Thessaloniki, GreeceLaboratory of Biochemistry, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, GreeceBasic and Translational Research Unit, Special Unit for Biomedical Research and Education, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceInstitute of Molecular Biology and Biotechnology, Foundation of Research and Technology, Heraklion, GreeceFunctional Proteomics and Systems Biology (FunPATh)—Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Thessaloniki, GreeceLaboratory of Biochemistry, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, GreeceLaboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, GreeceLaboratory of Microbiology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceInstitute of Molecular Biology and Biotechnology, Foundation of Research and Technology, Heraklion, GreeceFunctional Proteomics and Systems Biology (FunPATh)—Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Thessaloniki, GreeceLaboratory of Biochemistry, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, GreeceBasic and Translational Research Unit, Special Unit for Biomedical Research and Education, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, GreeceInstitute of Molecular Biology and Biotechnology, Foundation of Research and Technology, Heraklion, GreeceLaboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, GreeceFunctional Proteomics and Systems Biology (FunPATh)—Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Thessaloniki, GreeceDepartment of Life and Health Sciences, University of Nicosia, Nicosia, CyprusHeterogeneity of the main ribosomal composition represents an emerging, yet debatable, mechanism of gene expression regulation with a purported role in ribosomopathies, a group of disorders caused by mutations in ribosomal protein genes (RPs). Ribosomopathies, mysteriously relate with tissue-specific symptoms (mainly anemia and cancer predisposition), despite the ubiquitous expression and necessity of the associated RPs. An outstanding question that may shed light into disease pathogenicity and provide potential pharmacological interventions, is whether and how the ribosomal composition is modified during, the highly affected by RP mutations, process of erythroid differentiation. To address this issue, we analyzed ribosome stoichiometry using an established model of erythroid differentiation, through sucrose gradient ultracentrifugation and quantitative proteomics. We found that differentiation associates with an extensive reprogramming of the overall ribosomal levels, characterized by an increase in monosomes and a decrease in polysomes. However, by calculating a stoichiometry score for each independent ribosomal protein, we found that the main ribosomal architecture remained invariable between immature and differentiated cells. In total, none of the 78 Ribosomal Proteins (RPs- 74 core RPs, Rack1, Fau and 2 paralogs) detected was statistically different between the samples. This data was further verified through antibody-mediated quantification of 6 representative RPs. Moreover, bioinformatic analysis of whole cell proteomic data derived out of 4 additional models of erythropoiesis revealed that RPs were co-regulated across these cell types, too. In conclusion, ribosomes maintain an invariant protein stoichiometry during differentiation, thus excluding ribosome heterogeneity from a potential mechanism of toxicity in ribosomopathies and other erythroid disorders.https://www.frontiersin.org/articles/10.3389/fmolb.2022.805541/fullribosomopathiesribosomal proteinserythropoiesisproteomicsmass spectrometry
spellingShingle Christos I. Papagiannopoulos
Konstantinos A. Kyritsis
Konstantina Psatha
Konstantina Psatha
Konstantina Psatha
Konstantina Psatha
Dimitra Mavridou
Dimitra Mavridou
Fani Chatzopoulou
Fani Chatzopoulou
Georgia Orfanoudaki
Michalis Aivaliotis
Michalis Aivaliotis
Michalis Aivaliotis
Michalis Aivaliotis
Ioannis S. Vizirianakis
Ioannis S. Vizirianakis
Ioannis S. Vizirianakis
Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
Frontiers in Molecular Biosciences
ribosomopathies
ribosomal proteins
erythropoiesis
proteomics
mass spectrometry
title Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
title_full Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
title_fullStr Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
title_full_unstemmed Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
title_short Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
title_sort invariable ribosome stoichiometry during murine erythroid differentiation implications for understanding ribosomopathies
topic ribosomopathies
ribosomal proteins
erythropoiesis
proteomics
mass spectrometry
url https://www.frontiersin.org/articles/10.3389/fmolb.2022.805541/full
work_keys_str_mv AT christosipapagiannopoulos invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT konstantinosakyritsis invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT konstantinapsatha invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT konstantinapsatha invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT konstantinapsatha invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT konstantinapsatha invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT dimitramavridou invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT dimitramavridou invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT fanichatzopoulou invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT fanichatzopoulou invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT georgiaorfanoudaki invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT michalisaivaliotis invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT michalisaivaliotis invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT michalisaivaliotis invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT michalisaivaliotis invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT ioannissvizirianakis invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT ioannissvizirianakis invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies
AT ioannissvizirianakis invariableribosomestoichiometryduringmurineerythroiddifferentiationimplicationsforunderstandingribosomopathies